Nick Peters-Golden

It’s hard to avoid the daily market headlines touting huge moves for AI firms, or the latest volatility from the Strait of Hormuz. However, events-based news often obfuscates the subtler stories that can really define a portfolio’s performance. This year, concentration risk is shaping up to be one of the defining stories — and there’s no time like the present to address it.

Value investing and investor portfolios can sometimes feel like an endless “will they, won’t they?” story. Investors often wait for the right sign or moment to add value exposure, but frequently balk for fear of losing out on growthier upside. Thanks to ETFs, however, investors can get flexible, low-cost options in the value ETF space that outperform — like the

While healthcare stocks may not always seem the most enticing, they’ve quietly surged over the last month. The active healthcare tech ETF, FMED, which focuses on industry disruptors, saw its June performance significantly leapfrog its overall YTD numbers. What’s driving this sudden spike, and can the fund play a meaningful role in portfolios for the second half of the year?

Clients looking for income? Not satisfied with your core fixed income allocation and want to add some oomph? The American Century Short Duration Strategic Income ETF (SDSI) could provide the right boost to a core allocation with its status as an active, core-plus income strategy. That type of active income ETF could arrive at a key moment as rising inflation looms.

The ETF landscape continues to grow in leaps and bounds, with active ETFs playing an increasingly bigger role. Goldman Sachs is helping drive this evolution by leveraging its deep research and quantitative capabilities to innovate within the space. Leaders from Goldman Sachs Asset Management recently joined a VettaFi webinar to showcase this approach with their new ETF, the Goldman Sachs Data Enhanced International Equity ETF (GIEQ).

Small-caps have produced modest but healthy gains this year. After a slow start, the notable small-caps index Russell 2000 has returned 17.3% YTD. That has helped that same index return 30.7% over the last 12 months. Small-caps can produce helpful diversification and returns, but how best to approach them? A pair of ETFs from American Century offer both value and growth approaches to the space that can appeal.

Derivative-based ETFs are pushing half a trillion in AUM right now, as investors have flocked to the growing category. Amid that rising interest in recent years, however, other investors may have questions. What is included in the derivative ETF landscape? A recent VettaFi webinar focusing on derivative ETFs included insight from T. Rowe Price leaders on the kind of ETFs available in that space.

There are some serious opportunities and yields available in corporate bonds right now. For investors, the challenge is how to best access them. Thankfully, ETFs offer a variety of flexible, tradable strategies to help craft a bespoke allocation in portfolios. The American Century Select High Yield ETF (AHYB) and the American Century Diversified Corporate Bond ETF (KORP) pair together nicely to deliver just that.

ETFs allow investors a plethora of ways to express themselves while also pursuing performance. With each passing year, new ETFs arrive to help investors meet their personal and financial goals. The Defiance Autism Impact ETF (ASD) aims to invest in supporting individuals on the autism spectrum, while also providing some positive returns.

Goldman Sachs Asset Management (GSAM) recently expanded its ETF lineup via the acquisition of Innovator ETFs. In addition to Innovator’s notable suite of buffer ETFs, the deal also brings exciting active strategies like the